• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Takeda (Group)

Located in Osaka, Japan, Takeda is a research based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for patients worldwide through leading innovation in medicine. *

 

	Start	1990-01-01 existent
	Industry	pharmaceutical
	Street	1-1 Doshomachi 4-chome Chuo-ku
	City	540-8645 Osaka
	Tel	+81-6-6204-2111
		Address record changed: 2020-12-02
Basic data	Employees	H: 10,001 to 50,00 (2016-03-31)
	Currency	USD
	Annual sales	16,137,304,000 (revenue, consolidated (15/16) 2016-03-31)
	Profit	745,357,000 (2016-03-31)
	Cash	4,030,589,000 (2016-03-31)
		* Document for �About Section�:
		Record changed: 2020-04-06

Advertisement

More documents for Takeda (Group)

• [1] Evotec SE. (3/22/21). "Press Release: Evotec and Takeda Enter Strategic RNA Targeting Drug Discovery and Development Alliance". Hamburg....
• [2] Enterome S.A.. (9/23/20). "Press Release: Enterome Announces First Patient Dosed in Phase 2a Trial of Sibofimloc in Crohn’s Disease". Paris & Cambridge, MA....
• [3] Engitix Ltd.. (8/25/20). "Press Release: Engitix Signs Collaboration and Licensing Agreement with Takeda to Develop Anti-Fibrotic Therapies in Advanced Liver Diseases". London....
• [4] Egle Therapeutics S.A.S.. (6/11/20). "Press Release: Egle Therapeutics Enters Into a Corporate Strategic Research Alliance with Takeda to Uncover Novel Tumor-specific Regulatory T-cell Targets and Develop Unique Anti-Suppressor-Based Immunotherapies". Pa...
• [5] Evotec SE. (4/6/20). "Press Release: Evotec and Takeda Enter into Multi-year Gene Therapy Research Alliance". Hamburg....
• [6] Evox Therapeutics Ltd.. (3/26/20). "Press Release: Evox Therapeutics and Takeda Sign Multi-target Rare Disease Collaboration"....
• [7] Evotec SE. (3/26/20). "Press Release: Evotec SE Fiscal Year 2019 Results". Hamburg....
• [8] Evotec SE. (9/24/19). "Press Release: Evotec and Takeda Enter Collaboration Agreement to Discover Clinical Candidates across Multiple Therapeutic Areas". Hamburg....
• [9] H. Lundbeck A/S. (9/20/19). "Press Release: Lundbeck and Takeda Announce Ministry of Health, Labour and Welfare (MHLW) Approval of Trintellix in Japan"....
• [10] Adrenomed AG. (8/29/19). "Press Release: Adrenomed Supervisory Board Appoints Jens Schneider-Mergener as CEO and Jens Zimmermann, CMO, Joins the Executive Board". Hennigsdorf....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.